Please ensure Javascript is enabled for purposes of website accessibility

CVS Health and Walgreens to Administer Free Coronavirus Vaccines

By Cory Renauer – Updated Oct 16, 2020 at 4:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Trump administration has worked out a deal with America's largest retail pharmacy chains.

President Trump announced a coronavirus vaccine deal with two of the country's largest retail pharmacy chains, CVS Health (CVS 0.19%) and Walgreens (WBA 0.38%), during a speech in Florida on Friday afternoon.

The Pharmacy Partnership for Long-term Care Program is a new arrangement between the U.S. Department of Health and Human Services (HHS), the Department of Defense (DOD), CVS Health, and Walgreens. Once a vaccine becomes available, vaccines administered by one of the pharmacy chains partnered with the government will not be attached to any out-of-pocket costs. 

Pharmacist stocking shelves.

Image source: Getty Images.

There are dozens of coronavirus vaccines in clinical-stage testing, but none of them have had enough time to be proven safe and effective. BNT162, a first-in-class vaccine based on messenger RNA (mRNA) technology from BioNTech (BNTX 1.26%) and its big pharma partner Pfizer (PFE -0.61%), could be ready by the end of November, and this is arguably the front runner at the moment.

In July, the U.S. government placed an initial order for 100 million doses of BNT162 for $1.95 billion and secured an option to acquire an additional 500 million doses.

Beginning Oct. 19, 2020, long-term care facility operators can opt in and select CVS or Walgreens as their preferred pharmacy partner. Once the FDA authorizes the emergency use of a vaccine, facilities can begin setting appointments to receive the medication. All of the vaccine programs in late-stage clinical trials rely on a booster shot, and the DOD anticipates three total visits over about two months. 

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Stock Quote
CVS Health
CVS
$100.60 (0.19%) $0.19
Walgreens Boots Alliance Stock Quote
Walgreens Boots Alliance
WBA
$40.97 (0.38%) $0.15
Pfizer Stock Quote
Pfizer
PFE
$49.27 (-0.61%) $0.30
BioNTech SE Stock Quote
BioNTech SE
BNTX
$163.53 (1.26%) $2.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.